Filana Therapeutics, Inc. (formerly Cassava Sciences, Inc.) is a clinical-stage biotechnology company based in Austin, Texas, focused on developing medicines for CNS disorders. Its lead drug candidate, simufilam, is a proprietary small molecule oral treatment targeting filamin A protein, currently being studied for TSC-related epilepsy after discontinuing its Alzheimer's disease program in 2025. The company owns nine issued U.S. patents and holds an exclusive worldwide license from Yale University for simufilam's TSC-related applications.
expected 2026-12-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001437749-26-007962 | EDGAR | 72K words |
| 2025-03-03 | 2024-12-31 | 0001437749-25-005919 | EDGAR | 80K words |
| 2024-02-28 | 2023-12-31 | 0001437749-24-005894 | EDGAR | 78K words |
| 2023-02-28 | 2022-12-31 | 0001069530-23-000009 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001069530-22-000011 | EDGAR | — |
| 2021-03-23 | 2020-12-31 | 0001069530-21-000020 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001069530-20-000009 | EDGAR | — |
| 2019-03-29 | 2018-12-31 | 0001069530-19-000019 | EDGAR | — |
| 2018-02-06 | 2017-12-31 | 0001069530-18-000004 | EDGAR | — |
| 2017-03-07 | 2016-12-31 | 0001069530-17-000008 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-29 | 2026-06-30 | 0001437749-26-024752 | EDGAR | 20K words |
| 2025-11-12 | 2025-09-30 | 0001437749-25-034427 | EDGAR | 25K words |
| 2025-08-14 | 2025-06-30 | 0001437749-25-026686 | EDGAR | 24K words |
| 2025-05-08 | 2025-03-31 | 0001437749-25-015478 | EDGAR | 22K words |
| 2024-11-07 | 2024-09-30 | 0001437749-24-033944 | EDGAR | 30K words |
| 2024-08-08 | 2024-06-30 | 0001437749-24-025611 | EDGAR | 28K words |
| 2024-05-10 | 2024-03-31 | 0001437749-24-016040 | EDGAR | 24K words |
| 2023-11-07 | 2023-09-30 | 0001437749-23-030502 | EDGAR | 24K words |
| 2023-08-03 | 2023-06-30 | 0001069530-23-000039 | EDGAR | 20K words |
| 2023-05-01 | 2023-03-31 | 0001069530-23-000017 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0001069530-22-000058 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001069530-22-000033 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-22 | 0001171843-26-006161 | EDGAR | 1K words |
| 2026-09-18 | 0001437749-26-030751 | EDGAR | 1K words |
| 2026-07-29 | 0001171843-26-004982 | EDGAR | 2K words |
| 2026-03-12 | 0001171843-26-001506 | EDGAR | 3K words |
| 2026-03-10 | 0001437749-26-007422 | EDGAR | 11K words |
| 2026-02-19 | 0001171843-26-000922 | EDGAR | 1K words |
| 2025-12-23 | 0001437749-25-038605 | EDGAR | 1K words |
| 2025-12-18 | 0001437749-25-038313 | EDGAR | 1K words |
| 2025-12-17 | 0001437749-25-038157 | EDGAR | 1K words |
| 2025-12-03 | 0001437749-25-036710 | EDGAR | 1K words |
344 total filings indexed. 312 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001069530 |
| Ticker | FLNA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Austin, Texas |
| Website | https://www.filanatx.com |
| Listed | 2000-07-14 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/FLNA (~200 tokens, structured JSON with cryptographic provenance)